RecruitingNot Applicable

Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants

Sweden128 participantsStarted 2025-03-25

Plain-language summary

The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.

Who can participate

Age range

15 Years – 29 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Between the ages of 15 and 29. * A score above the cut-off 1.75 on HSCL-25 * Has a refugee or migrant background * Has a good and stable internet connection * Has access to a computer, tablet or smartphone * Is fluent in reading and writing Arabic * Has the ability to dedicate time to take part in the intervention for 6-10 weeks. Exclusion Criteria: * Is suffering from a severe mental illness, such as psychosis or severe depression. * Is suffering from substance abuse * Is undergoing a psychological treatment * Has a high risk of suicide

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Hopkins Symptom Checklist-25 (HSCL-25)

Timeframe: Pre-intervention, up to 5 weeks, immediately after the intervention, 6 months after completion of the intervention

Trial details

NCT IDNCT06828276

SponsorKarolinska Institutet

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Shervin Shahnavaz, PhD

0046722154769 shervin.shahnavaz@ki.se

View on ClinicalTrials.gov More Depressive Symptoms trials